Derek S. Gilchrist
Amministratore Delegato presso Causeway Therapeutics Ltd.
Provenienza dei contatti di primo grado di Derek S. Gilchrist
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Causeway Therapeutics Ltd.
Causeway Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Causeway Therapeutics Ltd. operates as a biotechnology company. It develops drugs for the treatment for patients. The company was founded by Derek S. Gilchrist and Neal L. Millar and is headquartered in Glasgow, the United States.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Derek S. Gilchrist tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
TENAX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
AMARIN CORPORATION PLC | Pharmaceuticals: Major | Chief Executive Officer | |
BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
PORTAGE BIOTECH INC. | Biotechnology | Chief Executive Officer | |
Tensys Medical, Inc.
Tensys Medical, Inc. Medical/Nursing ServicesHealth Services Tensys Medical, Inc. develops blood pressure monitoring systems. The firm provides patient safety by designing, and manufacturing continuous, non-invasive hemodynamic monitoring systems. The company was founded in 1995 and is headquartered in San Diego, CA. | Medical/Nursing Services | President | |
INTENSITY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
University of Glasgow | College/University | Doctorate Degree | |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Corporate Officer/Principal | |
University of Strathclyde | College/University | Undergraduate Degree | |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of Aston | College/University | Doctorate Degree | |
NXERA PHARMA CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Biotechnology | Corporate Officer/Principal | |
Heptares Therapeutics Ltd.
Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Pfizer Europe International Ltd.
Pfizer Europe International Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Europe International Ltd. is an Irish company. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
BIOATLA, INC. | Biotechnology | Corporate Officer/Principal | |
Mologic Ltd.
Mologic Ltd. Miscellaneous Commercial ServicesCommercial Services Mologic Ltd. provides immunoassay research and development services. It products include TIMP-1 lateral flow kit, TIMP-2 lateral flow kit, human A1AT lateral flow kit and fMLP ELISA kit. The company was founded by Paul J. Davis and Mark Davis in 2003 and is headquartered in Thurleigh, the United Kingdom. | Miscellaneous Commercial Services | Chairman | |
Pfizer Japan, Inc.
Pfizer Japan, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Pfizer Japan, Inc. is a research and Japanese development pharmaceutical company founded in 1953. The company is based in Tokyo, Japan. The company's focus is on breakthroughs that greatly change patients' lives, contributing to the improvement of patients' health and life expectancy. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Harvard T.H. Chan School of Public Health | College/University | Corporate Officer/Principal | |
University of Kent | College/University | Doctorate Degree | |
Celleron Therapeutics Ltd.
Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. Celleron has deep relationships with Oxford University and is located on the Oxford Science Park. The British company focuses on the clinical development of new and innovative therapies to treat cancer. Celleron is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. The company's lead products are currently in clinical trials, and they have a biomarker platform that allows them to identify responsive patients. Celleron Therapeutics Ltd. was founded in 2004, and the CEO is Nick la Thangue. | Pharmaceuticals: Major | Director/Board Member | |
Portage Pharma Ltd.
Portage Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Portage Pharma Ltd. develops pharmaceutical products. The There is no available country named vg company was founded by Declan Doogan, Gregory H. Bailey. Bruce H. Littman has been the CEO of the company since 2013. Portage Pharma was acquired by Portage Biotech, Inc. on June 04, 2013 for $34.84 million. | Pharmaceuticals: Major | Founder | |
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Founder | |
COI Pharmaceuticals, Inc.
COI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology COI Pharmaceuticals, Inc. provides life science investors. It offers research and development infrastructure and industry mentors to the portfolio companies of Avalon Ventures. The company was founded in 2013 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
The Pulmonary Vascular Research Institute
The Pulmonary Vascular Research Institute Miscellaneous Commercial ServicesCommercial Services The Pulmonary Vascular Research Institute operates as a medical research charity. The non-profit company is based in Canterbury, UK. | Miscellaneous Commercial Services | Director/Board Member | |
University of Glasgow School of Medicine | College/University | Corporate Officer/Principal | |
iOX Therapeutics Ltd.
iOX Therapeutics Ltd. BiotechnologyHealth Technology iOX Therapeutics Ltd. provides cancer therapeutics services. The company was founded by Vincenzo Cerundolo in February 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman | |
Mediqventures Ltd.
Mediqventures Ltd. Finance/Rental/LeasingFinance Mediqventures Ltd. provides financing services for life science technologies. The private company is based in Douglas, UK. The British company was founded by Gregory H. Bailey. | Finance/Rental/Leasing | Corporate Officer/Principal | |
Cullinan Mica Corp.
Cullinan Mica Corp. Pharmaceuticals: MajorHealth Technology PDI Therapeutics, Inc. develops therapeutics that enhances the body’s ability to recognize and destroy tumor cells. The company is headquartered in La Jolla, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
SHATTUCK LABS, INC. | Biotechnology | Director/Board Member | |
TCR2 THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
Medisieve Ltd.
Medisieve Ltd. Medical SpecialtiesHealth Technology Medisieve Ltd. manufactures and supplies magnetic blood filtration equipment. The company was founded by George Frodsham and is headquartered in London, the United Kingdom. | Medical Specialties | Director/Board Member | |
Elasmogen Ltd.
Elasmogen Ltd. Pharmaceuticals: MajorHealth Technology Elasmogen Ltd. develops soloMER products for treatment of auto-immune mediated and inflammatory diseases. The company is headquartered in Aberdeen, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Kleo Pharmaceuticals, Inc.
Kleo Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Kleo Pharmaceuticals, Inc. is a biotechnology company, which engages in the development of biospecific compounds designed to emulate and enhance the activity of biologics. Its compounds are designed to direct the immune system to destroy cancerous or virally infected cells, and treatment of multiple myeloma and COVID-19. It offers Antibody Recruiting Molecules (ARMs),Synthetic Antibody Mimics (SyAMs), and Monoclonal Antibody Therapy Enhancers (MATEs) pipeline. The company was founded by David A. Spiegel and Roy Prieb in 2015 and is headquartered in New Haven, CT. | Miscellaneous Commercial Services | Director/Board Member | |
Juvenescence Ltd.
Juvenescence Ltd. Financial ConglomeratesFinance Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom. | Financial Conglomerates | Founder | |
Adanate, Inc.
Adanate, Inc. BiotechnologyHealth Technology Adanate, Inc. develops antibody therapeutics. The CEO of the American company is Chris Griffith. | Biotechnology | Chief Executive Officer | |
BYOMass, Inc.
BYOMass, Inc. Miscellaneous Commercial ServicesCommercial Services BYOMass, Inc. provides investment holding services. The company is headquartered in Sudbury, MA. | Miscellaneous Commercial Services | Director/Board Member | |
INSTIL BIO, INC. | Biotechnology | Director/Board Member | |
Health Enterprise East Ltd.
Health Enterprise East Ltd. Miscellaneous Commercial ServicesCommercial Services Health Enterprise East Ltd. is a British company that focuses on building the future of healthcare through technology innovation. The private company is based in Cambridge, UK. The company provides technology advisory and innovation management services to both industry and the NHS. | Miscellaneous Commercial Services | Director/Board Member | |
Cullinan MICA, Inc.
Cullinan MICA, Inc. Investment ManagersFinance Cullinan MICA, Inc. develops immune-oncology antibody. The company is headquartered in the United States. | Investment Managers | Director/Board Member | |
British Pharmaceutical Students Association | President | ||
Cullinan Mica Corp.
Cullinan Mica Corp. Pharmaceuticals: MajorHealth Technology Part of Cullinan Therapeutics, Inc., Cullinan Mica Corp. is a company that provides worldwide rights to CLN-619. The company is based in Cambridge, MA. The CEO of the company is Nadim Ahmed. | Pharmaceuticals: Major | Director/Board Member | |
Carbometrics Ltd.
Carbometrics Ltd. BiotechnologyHealth Technology Carbometrics Ltd. is a British company that specializes in developing a new glucose sensor chemistry using their proprietary biomimetic glucose binding molecules (GBM). The company is based in Bristol, UK. The company's mission is to help people with diabetes live more normal and longer lives by creating market-leading continuous glucose monitors (CGM). Carbometrics was founded in 2018 by Keith Joseph MacDonald, Anthony Davis, Harry Destecroix, and Andy Chapman. Andy Chapman has been the CEO since 2018. | Biotechnology | Director/Board Member | |
Kitasato University | College/University | Corporate Officer/Principal | |
Silarus Therapeutics, Inc.
Silarus Therapeutics, Inc. BiotechnologyHealth Technology Silarus Therapeutics, Inc. develops therapeutics targeting erythroferrone for the treatment of iron deficiency and iron overload disorders. The company was founded by Tomas Ganz, Sanford J. Madigan, and Elizabeta Nemeth in May 19, 2014 and is headquartered in La Jolla, CA. | Biotechnology | Chief Tech/Sci/R&D Officer |
Statistiche
Distribuzione geografica
Stati Uniti | 25 |
Regno Unito | 18 |
Giappone | 4 |
Irlanda | 3 |
Germania | 2 |
Settori
Health Technology | 31 |
Consumer Services | 9 |
Commercial Services | 8 |
Finance | 4 |
Health Services | 2 |
Posizioni
Director/Board Member | 27 |
Corporate Officer/Principal | 12 |
Chief Tech/Sci/R&D Officer | 10 |
Chairman | 9 |
Independent Dir/Board Member | 8 |
Contatti più connessi
Insiders | |
---|---|
Declan Doogan | 28 |
Neil Gibson | 20 |
Christopher Jones | 14 |
Neal L. Millar | 1 |
Gregor Cardow | 1 |
- Borsa valori
- Insiders
- Derek S. Gilchrist
- Connessioni Società